Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Botulinum toxin is not effective for treating male hair loss.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

STK11 gene polymorphism does not predict metformin response in PCOS.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

PRP is more effective than minoxidil and placebo for treating hair loss.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

PRP injections did not significantly improve hair growth.

French maritime pine bark extract significantly increased hair density in menopausal women.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.